For a decade, until her husband’s death three years ago at age 71, Brown patched together assistance from family to help pay ...
MedPage Today on MSN
Leading Drug Fails to Slow Alzheimer's Progression
High-sensitivity C-reactive protein (CRP) decreased significantly in the semaglutide group, with estimated treatment ratios ...
A new study reveals that obesity accelerated Alzheimer's blood biomarkers by 95% over five years, highlighting a strong ...
Washington University School of Medicine researchers presented a study linking obesity to an increase in the progression ...
Details from two large trials of Novo Nordisk's GLP-1 drug semaglutide showed it provided no cognitive benefit for people ...
For years, Los Altos resident Kim Wilford watched Alzheimer’s Disease rob her beloved mother-in-law of her memories, spirit ...
MedPage Today on MSN
Novel Alzheimer's Pill May Slow Decline in Some High-Risk Patients
Valiltramiprosate is a brain-penetrant small molecule that blocks amyloid from aggregating into toxic oligomers, which are ...
In an era with less political and cultural division — and less tech-driven diversion — the stunning advances in medicine seen ...
Phase 1 results show that SUL-238 is safe, well-tolerated, and demonstrates favorable pharmacokinetics with high CSF ...
Brittany Butts understands that for many families, Alzheimer's comes as a double burden. As a teenager, she watched not only ...
Morning Overview on MSN
AI may diagnose Alzheimer’s from your retina, Eric Topol says
Artificial intelligence is moving from the lab into the clinic, and one of its most provocative promises is that it might ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results